SCHEMBL5843886

SCHEMBL5843886

O=C(O)CNC(=O)OCCNc1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 10/20 0.46
ITGAV P06756 10/20 0.46
ITGB1 P05556 5/20 0.46
ITGB6 P18564 4/20 0.46
ITGB5 P18084 4/20 0.46
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.42
FABP1 P07148 1/20 0.42
FABP6 P51161 1/20 0.42
GAA P10253 1/20 0.42
ANPEP P15144 1/20 0.42
ITGA2B P08514 1/20 0.41
ITGA5 P08648 1/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
CYP2D6 P10635 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5844128 0.92 ITGB3 (0.52) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL12225870 0.85 HTT (0.47) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL12225577 0.82 NPC1 (0.58) GAANPC1PKMRAB9ASMN1; SMN2
SCHEMBL5844064 0.79 ITGAV (0.72) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL5844569 0.79 ITGAV (0.72) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL5844740 0.79 ITGAV (0.72) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL5843713 0.79 KMT2A (0.45) ITGB3ITGAVNPC1RAB9ASMN1; SMN2
SCHEMBL5845136 0.79 ITGB3 (0.55) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL5846040 0.78 ITGB3 (0.60) ITGB3ITGAVITGB1ITGB6ITGB5
Hydrochloric Acid SCHEMBL360682 0.77 GAA (0.56) ITGB3ITGAVCYP1A2FABP1FABP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135587-B2 Urea and urethane derivatives as integrin inhibitors MERCK PATENT GMBH (DE) 2006-11-14 US disclosed
EP-1343764-B1 UREA AND URETHANE DERIVATIVES AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2004-08-25 EP disclosed
US-20040063644-A1 Urea and urethane derivatives as integrin inhibitors MERCK PATENT GMBH (DE) 2004-04-01 US disclosed
EP-1343764-A1 UREA AND URETHANE DERIVATIVES AS INTEGRIN INHIBITORS MERCK PATENT GmbH (DE) 2003-09-17 EP disclosed
WO-2002050039-A1 UREA AND URETHANE DERIVATIVES AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063644-A1 Urea and urethane derivatives as integrin inhibitors ITGB1, ITGB2, ITGA1 ITGB3 7/4885ITGAV 16/4885ITGB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.